Archived – Hospira Healthcare Corporation Recalls Two Lots of Desferrioxamine Mesilate for Injection, BP (500 mg and 2 g format)
Critical priority
The issue
Product quality
Where it was sold
Canada (national)Reported in the official notice — confirm there.
Issued by
Health Canada
Read the official Government of Canada notice
All recallsRecallGuardian ranks, illustrates and rewrites recalls in plain language. The official notice is authoritative — confirm model numbers, lot codes, dates and remedies there.